Yuka Tanaka

5PUBLICATIONS
23CO-AUTHORS
Haematological tumoursGene and molecular therapyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 04, 2026
Interleukin-37 Enhances Liver NK Cell Cytotoxicity and Improves Recurrence-Free Survival in Hepatocellular Carcinoma Patients.

|Jun 07, 2022
Adoptive immunotherapy overcomes genetic susceptibility to bloodstream infections due to fc-gamma receptor polymorphisms after liver transplantation.

Seiichi Shimizu, Masahiro Ohira, Yuka Tanaka

|Sep 28, 2019
Everolimus enhances TRAIL-mediated anti-tumor activity of liver resident natural killer cells in mice.

Jamilya Saparbay, Yuka Tanaka, Naoki Tanimine

|Jul 24, 2019
Postoperative Portal Hypertension Enhances Alloimmune Responses after Living-Donor Liver Transplantation in Patients and in a Mouse Model.

Shinji Hashimoto, Takashi Onoe, Masataka Banshodani

|Mar 13, 2019
Cotransplantation of preactivated mesenchymal stem cells improves intraportal engraftment of islets by inhibiting liver natural killer cells in mice.

Nobuki Ishida, Kohei Ishiyama, Yoshihiro Saeki

Pageof 1

Frequent Collaborators

5 joint publications

Hideki Ohdan

2 joint publications

Masahiro Ohira

2 joint publications

Yuki Imaoka

1 joint publications

Nobuki Ishida